Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Surgery Today|August 21, 2021
Retrospective evaluation of the effect of Ninjin'yoeito in hepatocellular carcinoma patients treated with lenvatinibKatsuya Toshida, Shinji Itoh, Tomoharu Yoshizumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[Immune Response on Outcomes in Hepatocellular Carcinoma]Norifumi Iseda, Shinji Itoh, Takahiro Tomiyama, et al.
International Journal of Clinical Oncology|July 12, 2021
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinomaNorifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi, et al.
Cancer Science|April 25, 2022
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinomaNorifumi Iseda, Shinji Itoh, Katsuya Toshida, et al.
Surgical Case Reports|October 6, 2022
Caution for living donor liver transplantation with congenital portosystemic shunt: a case reportYoshihiro Nagao, Katsuya Toshida, Akinari Morinaga, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|July 15, 2021
Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinomaShinji Itoh, Tomoharu Yoshizumi, Takahiro Tomiyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2022
The ratio of serum des-gamma-carboxy prothrombin to tumor volume as a new biomarker for early recurrence of resected hepatocellular carcinomaTomonari Shimagaki, Tomoharu Yoshizumi, Shinji Itoh, et al.
Surgical Case Reports|February 3, 2017
Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case reportYoshihiro Yoshida, Tomoharu Yoshizumi, Huanlin Wang, et al.
Clinical Journal of Gastroenterology|January 20, 2021
Surgically resected hepatic mass caused by fascioliasisHuanlin Wang, Shinji Itoh, Yuji Matsumoto, et al.
Pageof 6